TP53 and myelodysplastic syndrome: These differences were even more pronounced in the TP53 mutant subset of CK-MDS, which were more likely to have high complexity, monosomal karyotypes, certain chromosomal abnormalities, and an even lower number of co-mutated myeloid malignancy genes.